Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation [Hematologic Malignancies]
Conclusion
The prospect for long-term survival is excellent for 2-year survivors of allogeneic HCT. However, life expectancy remains lower than expected. Performance of HCT earlier in the course of disease, control of GVHD, enhancement of immune reconstitution, less toxic regimens, and prevention and early treatment of late complications are needed. (Source: Journal of Clinical Oncology)
More
